Oncoinfluencers to Follow on Social Media: Dr. Paolo Tarantino
Our next oncoinfluencer is Dr. Paolo Tarantino.
Dr. Tarantino is active on both X/Twitter and LinkedIn, where he regularly shares comprehensive insights into oncology. His posts range from the latest research publications to in-depth discussions on patient care and advancements in breast oncology, with a particular focus on HER2 and antibody-drug conjugates (ADCs). Dr. Tarantino’s consistent and informative updates make him a valuable resource for anyone keen on staying abreast of breast oncology developments.
Stay updated with Dr. Tarantino’s latest research and insights by following him on social media:
X/Twitter:@PTarantinoMD
LinkedIn: Paolo Tarantino
About Paolo Tarantino
Dr. Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.
His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field.
While staying tuned for upcoming Oncoinfluencers, check out previous profiles on our website on influential voices in the oncology community.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023